Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice

Journal of Molecular Medicine

Volumn 77, Issue 11, 1999, Pages 792-797

  Jansen, Burkhard ^a   Heere Ress, Elisabeth ^a   Schlagbauer Wadl, Hermine ^a   Halaschek Wiener, Julius ^a   Waltering, Stephan ^b   Moll, Ingrid ^c   Pehamberger, Hubert ^a   Marciano, Daniele ^d   Kloog, Yoel ^e   Wolff, Klaus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Department of Dermatology ^*  (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

Merkel cell carcinoma; p53; S trans, trans farnesylthiosalicylic acid; SCID mouse

Indexed keywords

THIOSALICYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MERKEL CELL TUMOR; MODEL; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; XENOTRANSPLANTATION;

EID: 0033400494     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001099900052     Document Type: Article

References (42)

1. 1. Toker C (1972) Trabecular carcinoma of the skin. Arch Dermatol 105:107-110
2. 2. Moll I, Gillardon F, Waltering S, Schmelz M, Moll R (1996) Differences of bcl-2 protein expression between Merkel cells and Merkel cell carcinomas. J Cutan Pathol 23:109-117
3. 3. Ratner D, Nelson BR, Brown MD, Johnson TM (1993) Merkel cell carcinoma. J Am Acad Dermatol 29:143-159
4. 4. Haag ML, Glass F, Fenske N (1995) Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg 21:669-683
5. 5. Pectasides D, Moutzourides G, Dimitriadis M, Varthalitis J, Athanassiou A (1995) Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide. Am J Clin Oncol 18:418-420
6. 6. Sharma D, Flora G, Grunberg S (1991) Chemotherapy of metastatic Merkel cell carcinoma: case report and review of the literature. Am J Clin Oncol 14:166-169
7. 7. Ronan SG, Green AD, Shilkaitis A, Huang TS, Das Gupta TK (1993) Merkel cell carcinoma: in vitro and in vivo characteristics of a new cell line. J Am Acad Dermatol 29:715-722
8. 8. Baudoin C, Meneguzzi G, Portier MM, Demarchez M, Bernerd F, Pisani A, Ortonne JP (1993) Peripherin, a neuronal intermediate protein, is stably expressed by neuroendocrine carcinomas of the skin, their xenograft on nude mice, and the corresponding primary cultures. Cancer Res 53:1175-1181
9. 9. Sandbrink F, Muller L, Fiebig HH, Kovacs G (1988) Short communication: deletion 7q, trisomy 6 and 11 in a case of Merkel cell carcinoma. Cancer Genet Cytogenet 33:305-309
10. 10. Iwafuchi M, Watanabe H, Ishihara N, Takahashi Y, Yoshimura M (1986) A neuroendocrine (Merkel) cell carcinoma with co-existing intraepidermal squamous cell carcinoma of the skin. Its growth accelerated by a extrinsic factor. Acta Pathol Jpn 36:1099-1108
11. 11. Kolibaba KS, Druker BJ (1997) Protein tyrosine kinases and cancer. Biochem Biophys Acta 1333:F217-F248
12. 12. Huang HS, Nagane M, Klingbeil CK, Lin H, Nishikawa R, Ji XD, Huang CM, Gill GN, Wiley HS, Cavenee WK (1997) The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 272:2927-2935
13. 13. Smith JJ, Derynck R, Korc M (1987) Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci USA 84:7567-7570
14. 14. Pazin MJ, Williams LT (1992) Triggering signaling cascades by receptor tyrosine kinases. Trends Biochem Sci 17:374-378
15. 15. Rodeck U, Becker D, Herlyn M (1991) Basic fibroblast growth factor in human melanoma. Cancer Cells 3:308-311
16. 16. Boguski MS, McCormick F (1993) Proteins regulating ras and its relatives. Nature 366:643-654
17. 17. Lange-Carter CA, Johnson GL (1994) Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 265:1458-1461
18. 18. Bos JL (1997) Ras-like GTPases. Biochem Biophys Acta 1333:M19-M31
19. 19. Lowy DR, Willumsen BM (1993) Function and regulation of ras. Annu Rev Biochem 62:851-891
20. 20. Marshall CJ (1996) Ras effectors. Curr Opin Cell Biol 8:197-204
21. 21. Barbacid M (1987) Ras genes. Annu Rev Biochem 56:779-827
22. 22. Van Elsas A, Zerp SF, van der Flier S, Kruse KM, Aarnoudse C, Hayward NK, Ruiter DJ, Schrier PI (1996) Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol 149:883-893
23. 23. Marciano D, Ben-Baruch G, Marom M, Egozi Y, Haklai R, Kloog Y (1995) Farnesyl derivatives of rigid carboxylic acids-inhibitors of ras-dependent cell growth. J Med Chem 38:1267-1272
24. 24. Marom M, Haklai R, Ben-Baruch G, Marciano D, Egozi Y, Kloog Y (1995) Selective inhibition of ras-dependent cell growth by farnesylthiosalicylic acid. J Biol Chem 270:22263-22270
25. 25. Marciano D, Aharonson Z, Varsano T, Haklai R, Kloog Y (1997) Novel inhibitors of the prenylated protein methyltransferase reveal distinctive structural requirements. Bioorg Med Chem 7:1709-1714
26. 26. Aharonson Z, Gana-Weisz M, Varsano T, Haklai R, Marciano D, Kloog Y (1998) Stringent structural requirements for anti-ras activity of S-prenyl analogues. Biochem Biophys Acta 1406:40-50
27. 27. Haklai R, Weisz MG, Elad G, Paz A, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y (1998) Dislodgment and accelerated degradation of ras. Biochemistry 37:1306-1314
28. 28. Niv H, Gutman O, Henis YI, Kloog Y (1999) Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling. Evidence from lateral mobility studies. J Biol Chem 274:1606-1613
29. 29. Egozi Y, Weisz B, Gana-Weisz M, Ben-Baruch G, Kloog Y (1999) Growth inhibition of ras-dependent tumors in nude mice by a potent ras-dislodging antagonist. Int J Cancer 80:911-918
30. 30. Weisz B, Giehl K, Gana-Weisz M, Egozi Y, Ben-Baruch G, Marciano D, Gierschick P, Kloog Y (1999) A new functional ras antagonist inhibits human pancreatic tumor growth in nude mice. Oncogene (in press)
31. 31. Gana-Weisz M, Haklai R, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y (1997) The ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation. Biochem Biophys Res Commun 239:900-904
32. 32. Haring R, Fisher A, Marciano D, Pittel Z, Kloog Y, Zuckerman A, Eshhar N, Heldman E (1998) Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion. J Neurochem 71:2094-2103
33. 33. Paine-Murrieta GD, Taylor CW, Curtis RA, Lopez MHA, Dorr R, Johnson C, Funk CY, Thompson F, Hersh EM (1997) Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol 40:209-214
34. 34. Yiengpruksawan A, Coit DG, Thaler HT, Urmacher C, Knapper WK (1991) Merkel cell carcinoma. Prognosis and management. Arch Surg 126:1514-1519
35. 35. Gottlieb E, Haffner R, von Ruden T, Wagner EF, Oren M (1994) Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3 dependent hematopoietic cells following IL-3 withdrawal. EMBO J 13:1368-1374
36. 36. Lowe SW, Ruley HE (1993) Stabilization of the p53 tumor suppressor is induced by the adenovirus 5 E1 A and accompanies apoptosis. Genes Dev 7:535-545
37. 37. Agarwal MA, Taylor WR, Chernov MV, Chernova OB, Stark GR (1998) The p53 network. J Biol Chem 273:1-4
38. 38. Wagner AJ, Kokontis JM, Hay N (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf/cip1. Genes Dev 8:2817-2830
39. 39. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852
40. 40. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401-410
41. 41. Symons, M (1996) Rho family GTPases: the cytoskeleton and beyond. Trends Biochem Sci 21:178-181
42. 42. Joneson T, White MA, Wigler MH, Bar-Sagi D (1996) Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271:810-812